logo

For the Inventor, By the Inventor

Berwyn, PA, United States of America

Steven Siegel

This inventor holds 24 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents, primarily in Drug Delivery Systems. Top assignees: University of Pennsylvania, Nupathe Inc., Bio-Tech Medical Software, Inc.. Active years: 1998-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Siegel. Retrieved from https://idiyas.com/inventor/steven-siegel-bq2ctot2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 79.2


Average Co-Inventor Count = 1.5

ph-index = 10

Forward Citations = 657(Granted Patents)


Location History:

  • Brooklyn, NY (US) (1998 - 2007)
  • Fort Lauderdale, FL (US) (2011 - 2012)
  • Berwyn, PA (US) (2010 - 2020)

Company Filing History:

goldMedal15 out of 2,659 
 
University of Pennsylvania
 patents
silverMedal3 out of 10 
 
Nupathe Inc.
 patents
bronzeMedal1 out of 1 
 
Bio-Tech Medical Software, Inc.
 patent
4. 8 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
Risperidone
Biodegradable Implant
Controlled Release
Dopamine Treatment
Drug-Containing Implants
PLA Implants
Biometric Identification
Phonic Engine
Natural Language Processing
Auditory Navigation
Medication Monitoring
24 patents (USPTO):Explore Patents
1. 10736965 - Risperidone biodegradable implant (2020-08-11),
2. 10278916 - Implants for the treatment of dopamine associated states (2019-05-07),
3. 10111960 - 9-OH-risperidone controlled release composition (2018-10-30),
4. 9925268 - Drug-containing implants and methods of use thereof (2018-03-27),
5. 9895447 - Drug-containing PLA implants and methods of use thereof (2018-02-20),
6. 9717799 - Drug-containing implants and methods of use thereof (2017-08-01),
7. 9439905 - Risperidone-containing implants and methods of use thereof (2016-09-13),
8. 8802127 - Risperidone-containing PLA:PGA implants and methods of use thereof (2014-08-12),
9. 8758795 - Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use (2014-06-24),
10. 8741327 - Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant (2014-06-03),
11. 8475830 - Implants for the treatment of dopamine associated states (2013-07-02),
12. 8475829 - Implants for the treatment of dopamine associated states (2013-07-02),
13. 8335697 - System and method for monitoring medication prescriptions using biometric identification and verification (2012-12-18),
14. 8329203 - Drug-containing implants and methods of use thereof (2012-12-11),
15. 8221778 - Drug-containing implants and methods of use thereof (2012-07-17),

Title: Steven Siegel: Innovator in Biodegradable Drug Delivery Systems

Introduction

Steven Siegel, an accomplished inventor based in Berwyn, Pennsylvania, holds an impressive portfolio of 24 patents. His innovative work primarily revolves around biodegradable drug delivery systems designed to enhance treatment options for various medical conditions, particularly in the realm of psychiatric disorders.

Latest Patents

Among Steven's most notable inventions is the "Risperidone Biodegradable Implant," which presents an advanced method for delivering therapeutic drugs via a polymer framework that incorporates polylactic acid (PLA) and, optionally, polyglycolic acid (PGA). This invention allows for a sustained release of therapeutic drugs at a substantially linear rate and aims to effectively treat schizophrenia and related disorders. Additionally, Steven has developed "Implants for the Treatment of Dopamine Associated States," which consist of biodegradable implants containing dopamine-modulating compounds, offering promising solutions for conditions linked to dopamine imbalances.

Career Highlights

Throughout his career, Steven has contributed significantly to the field of biomedical engineering and drug delivery systems. His work at prestigious institutions, including the University of Pennsylvania, has been instrumental in advancing research and development in innovative therapeutic applications.

Collaborations

Steven has collaborated with esteemed colleagues, including Karen Winey and Terri Sebree, who have contributed their expertise to further enhance the impact of his inventions. These partnerships underscore the collaborative nature of innovation in the scientific community.

Conclusion

Steven Siegel's contributions to the field through his numerous patents exemplify the importance of innovation in developing effective medical treatments. His work continues to inspire future developments in drug delivery systems, ultimately aiming to improve patient outcomes in various therapeutic areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…